(Q34667729)

English

Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy (English)

1 reference

Europe PubMed Central

3 August 2017

1 reference

based on heuristic

inferred from title

breast carcinoma

1 reference

based on heuristic

inferred from title

author name string

Neal S Goldstein

1

1 reference

Europe PubMed Central

3 August 2017

David Decker

2

1 reference

Europe PubMed Central

3 August 2017

Dawn Severson

3

1 reference

Europe PubMed Central

3 August 2017

Scott Schell

4

1 reference

Europe PubMed Central

3 August 2017

Frank Vicini

5

1 reference

Europe PubMed Central

3 August 2017

Jeffrey Margolis

6

1 reference

Europe PubMed Central

3 August 2017

Nayana S Dekhne

7

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 October 2007

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

110

1 reference

Europe PubMed Central

3 August 2017

1687-1696

1 reference

Europe PubMed Central

3 August 2017

8

1 reference

Europe PubMed Central

3 August 2017

Primary systemic therapy in operable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Extending the indications for breast-conserving treatment to patients with locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Women age < or = 35 years with primary breast carcinoma: disease features at presentation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of histopathological evaluation in primary therapy for breast cancer--recent trends in primary modality with pathological complete response (pCR) as endpoint

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferating fraction during neoadjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular portraits of breast cancer: tumour subtypes as distinct disease entities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Histologic variants of infiltrating lobular carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive lobular carcinoma of the breast: incidence and variants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathologic features of breast cancer associated with complete response to neoadjuvant chemotherapy: importance of tumor necrosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of luminal and basal cytokeratins in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22981

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22981

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34667729&oldid=1615007145"